Performing a FeNO test with NIOX®

This video is intended for healthcare professionals.
NIOX VERO®, THE GOLD STANDARD IN FENO TESTING
With over 45 million FeNO tests performed worldwide, NIOX VERO® helps healthcare professionals to accurately measure Type 2 airway inflammation.
NIOX® technology eliminates the impact of environmental Nitric Oxide and ensures you get an accurate FeNO result each time, every time. NIOX VERO® is from Circassia, the world leader in FeNO testing.
FeNO is a biomarker of Type 2 inflammation that can improve the entire patient care continuum. FeNO testing is recommended in most guidelines for asthma diagnosis and management.
NIOX VERO® can help with:
Diagnosis: Identifying Type 2 inflammation and assisting in asthma diagnosis
Treatment: Determining ICS responsiveness and optimising ICS dosage
Compliance: Uncovering non-adherence to ICS treatment plan
Quality of life: Reducing exacerbations by 50%
Severe asthma: Identifying appropriate patients for biologics and monitoring patients’ response to biologics
Find out more about NIOX VERO® here:
niox.com
© Circassia Ltd